Chung Tae-Sung, Lim Seok-Byung, Sohn Dae Kyung, Hong Chang Won, Han Kyung Su, Choi Hyo Seong, Jeong Seung-Yong
Center for Colorectal Cancer, Research Institute & Hospital, National Cancer Center, 809 Madu1-dong, IIsandong-gu, Goyang-si, Gyeonggi-do, Korea.
World J Surg. 2008 Oct;32(10):2275-80. doi: 10.1007/s00268-008-9695-5.
The present study investigated the feasibility of a single-stage operation consisting of self-expandable metallic stent (SEMS) placement followed by laparoscopic surgery for obstructive left colorectal cancer.
From July 2002 to March 2007, 17 consecutive patients with primary obstructive left colorectal cancer underwent SEMS placement followed by laparoscopic surgery. Data were collected retrospectively regarding clinicopathological findings, SEMS placement, operative procedures, and perioperative outcomes. Technical success was defined as successful stent deployment across the obstructive lesion, and clinical success as the possibility of performing a single-stage operation without creating a stoma.
In the laparoscopic group, the technical success rate was 100% (17/17) and there was no morbidity associated with SEMS placement. The median interval to laparoscopic surgery was 7 (range, 2-11) days, and the procedures included 11 anterior resections, 3 left hemicolectomies, 2 Hartmann's procedures, and 1 subtotal colectomy. All procedures were completed laparoscopically without conversion to open surgery. The median operating time was 178 (range, 93-377) minutes, and the median estimated blood loss was 100 (range, 50-400) ml with no cases requiring intraoperative transfusions. The clinical success rate was 82.4% (14/17), and there was no surgical morbidity other than two patients in whom chyloperitoneum and ileus were controlled by using conservative management. The median postoperative hospital stay was 9 (range, 7-49) days.
A single-stage operation consisting of SEMS placement followed by laparoscopic surgery seems to be a feasible and safe treatment option for obstructive left colorectal cancer.
本研究探讨了自膨式金属支架(SEMS)置入后行腹腔镜手术治疗梗阻性左半结肠癌的单阶段手术的可行性。
2002年7月至2007年3月,17例连续性原发性梗阻性左半结肠癌患者接受了SEMS置入,随后行腹腔镜手术。回顾性收集有关临床病理特征、SEMS置入、手术操作及围手术期结果的数据。技术成功定义为支架成功跨过梗阻病变展开,临床成功定义为能够进行无造口的单阶段手术。
在腹腔镜组中,技术成功率为100%(17/17),且SEMS置入无相关并发症。至腹腔镜手术的中位间隔时间为7天(范围2 - 11天),手术包括11例前切除术、3例左半结肠切除术、2例Hartmann手术和1例结肠次全切除术。所有手术均在腹腔镜下完成,未中转开腹。中位手术时间为178分钟(范围93 - 377分钟),中位估计失血量为100毫升(范围50 - 400毫升),无病例需要术中输血。临床成功率为82.4%(14/17),除2例患者通过保守治疗控制乳糜腹和肠梗阻外,无手术相关并发症。术后中位住院时间为9天(范围7 - 49天)。
由SEMS置入后行腹腔镜手术组成的单阶段手术似乎是梗阻性左半结肠癌一种可行且安全的治疗选择。